Viatris, formed from Mylan and Pfizer's Established Brands, has faced stock price volatility since its inception in 2020. I rated Viatris a "Buy" last October, based on management's completion of ...

As Leo stands in his office, overseeing the entrance of Viatris' bustling office in the Netherlands, he reflects on the 50 years that have shaped his journey with the company. From his early days ...

Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, is a leading global healthcare company dedicated to empowering people worldwide to live healthier at every stage of life. With a ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

When Chevrolet introduced the Vega 2300 to the public in September of 1970, performance enthusiasts immediately scoped out the dimensions of the engine compartment and began speculating on the ...

Zooming in further, Viatris has lagged behind the SPDR S&P Pharmaceuticals ETF’s 6.3% gains over the past 52 weeks and 4.8% return in 2025. On Nov. 7, Viatris announced its third-quarter ...

Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer patient ...

Viatris' earnings beat was driven by effective cost management. For fiscal 2024, analysts anticipate Viatris to report an EPS of $2.68, down 8.5% from $2.93 in fiscal 2023 .

Languages: English. As wildfires in Los Angeles began to subside late last week, Baja California, just south of the U.S.-Mexico border, faced its own wave of devastating blazes. Satellite images ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.